J&J CONTRACT WITH PUGET SOUND REDUCED QUINOLONE USE 25%, INCREASED FLOXIN SHARE; HEALTH CARE SYSTEMS AT J&J OFFERS "ONE-STOP SHOPPING" TO MANAGED CARE

A disease management contract between Johnson & Johnson and Group Health of Puget Sound produced a 25% reduction in use of quinolone antibiotics while increasing the market share of J&J's quinolone Floxin from 10% to 30%, J&J Health Care Systems Chairman Dennis Longstreet told the Alex. Brown health care seminar in Baltimore May 17.